ArticleMolecular biology reports2026
Baicalin ameliorates acute pancreatitis through inhibiting the activation of cGAS/STING signaling pathway.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBaicalin, a compound derived from natural sources, has demonstrated potential for alleviating inflammation and pain associated with acute pancreatitis (AP). This study aimed to evaluate the therapeutic efficacy and underlying mechanisms of baicalin in AP. METHODS AND
resultsThe role of baicalin in AP was evaluated both in vivo and in vitro. Pancreatic damage was assessed via histopathological examinations and serum enzyme measurements. The activation of the cGAS/STING signaling pathway was investigated under AP conditions both in vivo and in vitro. Knockdown of cGAS was employed to validate the involvement of the cGAS/STING signaling pathway in AP. Additionally, overexpression of cGAS and an agonist of STING were utilized to explore the mechanisms through which baicalin alleviates AP. Baicalin significantly reduced serum levels of lipase and amylase and alleviated pancreatic edema. Following treatment with baicalin, apoptosis and reactive oxygen species (ROS) levels in AP mice were diminished, as indicated by results from TUNEL and DHE staining assays. In both in vivo and in vitro studies, baicalin notably inhibited the expression of the cGAS/STING signaling pathway, along with downstream factors, including NLRP3, IL-1β, and IL-18. Knockdown of cGAS resulted in a significant reduction of apoptosis and inflammation in the pancreatic acinar cell line AR42J. Conversely, both genetic and pharmacological overexpression of cGAS/STING pathway negated the protective effects of baicalin on anti-apoptosis and anti-inflammation.
conclusionsIn conclusion, our data suggest that baicalin may attenuate AP by suppressing the cGAS/STING signaling pathway.
Indexed as
Identifiers
42334503What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.